The UK has its own separate framework following Brexit, with the MHRA providing guidance on research chemical imports
These risks are very real
Tirzepatide is a dual-agonist , meaning it works by targeting two hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Retatrutide is a triple-agonist , meaning it targets three hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Glucagon: affects energy use and fat metabolism Early studies show that retatrutide may be more successful than tirzepatide at managing diabetic kidney disease, as well as for weight control, while tirzepatide may be better at managing blood glucose
Unlike GLP-1 receptor agonists, metformin does not directly suppress appetite or act on central hunger pathways
What are the side effects of Isotretinoin (Accutane)
The first two weeks are the adjustment window